AEGON Asset Management (UK)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.37M | Sell |
202,546
-25,858
| -11% | -$1.2M | 0.12% | 117 |
|
|
2025
Q1 | $13.9M | Buy |
228,404
+3,139
| +1% | +$192K | 0.2% | 105 |
|
|
2024
Q4 | $12.7M | Sell |
225,265
-29,605
| -12% | -$1.68M | 0.17% | 111 |
|
|
2024
Q3 | $13.2M | Sell |
254,870
-56,106
| -18% | -$2.9M | 0.18% | 115 |
|
|
2024
Q2 | $12.9M | Hold |
310,976
| – | – | 0.18% | 113 |
|
|
2024
Q1 | $16.9M | Sell |
310,976
-56,522
| -15% | -$3.07M | 0.25% | 71 |
|
|
2023
Q4 | $18.8M | Buy |
+367,498
| New | +$18.8M | 0.3% | 73 |
|
|
2023
Q2 | $28.4M | Sell |
443,397
-655,371
| -60% | -$41.9M | 0.46% | 59 |
|
|
2023
Q1 | $76.1M | Sell |
1,098,768
-13,332
| -1% | -$923K | 1.33% | 18 |
|
|
2022
Q4 | $80M | Buy |
1,112,100
+8,334
| +0.8% | +$599K | 1.45% | 18 |
|
|
2022
Q3 | $78.5M | Buy |
1,103,766
+277,717
| +34% | +$19.8M | 1.59% | 16 |
|
|
2022
Q2 | $63.7M | Buy |
+826,049
| New | +$63.7M | 1.2% | 23 |
|
|
2020
Q3 | – | Sell |
-53,749
| Closed | -$3.16M | – | 148 |
|
|
2020
Q2 | $3.16M | Hold |
53,749
| – | – | 0.07% | 97 |
|
|
2020
Q1 | $2.99M | Buy |
53,749
+6,670
| +14% | +$371K | 0.09% | 89 |
|
|
2019
Q4 | $3.02M | Hold |
47,079
| – | – | 0.07% | 103 |
|
|
2019
Q3 | $2.39M | Hold |
47,079
| – | – | 0.06% | 113 |
|
|
2019
Q2 | $2.13M | Buy |
+47,079
| New | +$2.13M | 0.06% | 112 |
|
|
2018
Q4 | – | Sell |
-3,693
| Closed | -$229K | – | 167 |
|
|
2018
Q3 | $229K | Buy |
+3,693
| New | +$229K | 0.01% | 181 |
|